Plotting career choices beyond the lab

Cold Spring Harbor Laboratory's Technology Transfer Chief Teri WilleyCold Spring Harbor Laboratory's technology transfer chief, Teri Willey.

In what may be a collaborative first for Long Island’s innovation community, all of the region’s top research institutions will come together – along with representatives of the nation’s biggest pharmaceutical conglomerates – to lead life science out of the laboratory.

“Beyond Academia: Bench to Bioscience Enterprise” is a day-long forum on “career paths and strategies outside the lab,” scheduled for Friday at Cold Spring Harbor Laboratory’s Wendt Laboratory. The program is a collaborative effort between CSHL’s Postdoc Liaison Committee and the laboratory’s Business Development and Technology Transfer office, in conjunction with the Center for Biotechnology, a New York State Center for Advanced Technology on the Stony Brook University campus.

Brookhaven National Laboratory, SBU, Columbia University, the Hofstra Northwell School of Medicine and the Feinstein Institute for Medical Research – Northwell Health’s R&D wing – are all institutional partners for the April 22 event.

Featuring panel discussions, corporate presentations and various networking events, “Beyond Academia” is designed to “broaden knowledge of potential career paths in life sciences for individuals with advanced degrees who are interested in pursuing a non-

research based career” in the bioscience and biotechnology industries, CSHL said in a statement.

On hand will be executives from several large-scale U.S. pharmaceutical companies, including Eli Lilly and Co., Merck & Co., Farmingdale-based Enzo Life Sciences and AstraZeneca. Also scheduled to participate are guest speakers from Accelerate Long Island, the New York Blood Center and various life science-focused consultancies, all chipping in to help participants better understand potential career for scientists not interested in formulating the next biomedical breakthrough.

Panned panel discussions include “Commercializing Science,” moderated by new CSHL Executive in Residence Andrew Whiteley; “Professional Skill-Building for Non-Bench Science Careers,” led by Saied Tousi, managing director of Locust Valley-based financial consultants NW Advisors; and “Interviewing Skills for Non-Bench Careers,” moderated by Jennifer Hsieh of CSHL’s Technology Transfer office.

Other panel discussions on the agenda: “Careers in Consulting,” moderated by consultant Kenneth Hess of Wading River-based business-strategy consultancy Defined Health; “Careers in Venture Capital,” led by Brandy Houser of California-based Celdara Medical’s New York office; and “Careers in Business Development in Big Pharma,” moderated by Teri Willey, CSHL’s technology transfer guru.

Also scheduled are several networking sessions, as well as lunch seminars exploring specific career opportunities at participating Big Pharma companies and at Garden City-based IP law firm Scully Scott Murphy & Presser. Michael Gutch, AstraZeneca’s executive director of corporate development, is slated to deliver the keynote address.